eculizumab (Soliris) Last Updated: February 25, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: eculizumab Indications: Neuromyelitis optica spectrum disorder Brand Name: SolirisManufacturer: Alexion Pharma Canada Corp.Project Number: SR0640-000Project Status: ReceivedSubmission Type: New Indication Details
Pembrolizumab (Keytruda) for Mismatch Repair Deficient Endometrial Cancer - Details Last Updated: February 25, 2020 Result type: Reports Product Line: Pan Canadian Oncology Drug Review
Pembrolizumab (Keytruda) for Mismatch Repair Deficient Colorectal Cancer - Details Last Updated: February 25, 2020 Result type: Reports Product Line: Pan Canadian Oncology Drug Review
Body Weight Modification Interventions for Chronic, Non-Cancer Pain: Clinical Effectiveness and Guidelines Last Updated: February 24, 2020 Result type: Reports Product Line: Rapid Response Research Type: Device Project Number: RA1085-000 Details
Inotropes and Vasopressors for Septic or Cardiogenic Shock in Rural Settings: Guidelines Last Updated: February 24, 2020 Result type: Reports Product Line: Rapid Response Research Type: Drug Project Number: RB1444-000 Details
Combination Use of Ivabradine with Sacubitril/Valsartan: A Review of Clinical Effectiveness and Guidelines Last Updated: February 24, 2020 Result type: Reports Product Line: Rapid Response Research Type: Drug Project Number: RC1247-000 Details
Niraparib (Zejula) for Ovarian Cancer - Details Last Updated: February 24, 2020 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10203 Details
Darolutamide (Nubeqa) for Non-Metastatic Castration Resistant Prostate Cancer – Details Last Updated: February 24, 2020 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10196 Details
Amino Acids and Related Supplements for Mild Traumatic Brain Injury: Clinical Effectiveness Last Updated: February 24, 2020 Result type: Reports Product Line: Rapid Response Research Type: Drug Project Number: RB1449-000 Details
Ondansetron and Oral Rehydration Therapy in Pediatric Patients with Dehydration: Clinical Effectiveness Last Updated: February 24, 2020 Result type: Reports Product Line: Rapid Response Project Number: RC1242-000 Details
